ArticleFrontiers in computational neuroscience2026
Rehab-DRLX: explainable neurorehabilitation prognosis using deep reinforcement learning and transformer-based models.
Article in Frontiers in computational neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurorehabilitation poses a crucial problem in clinical recovery tasks, particularly for individuals with poor motor functions and neurological impairments, and problems in activities of daily living (ADL). To resolve this, we design a novel model, Rehab-DRLX, with a hybrid deep learning (HDL) framework that combines deep reinforcement learning (DRL) with an explainable transformer model to provide interpretable, accurate prognostic results. The propounded model is designed to effectively process the multimodal data inputs, which include clinical records, sensor-entrenched motion data, and neuroimaging, along with time-dependent recovery patterns from its reinforced representation learning (RRL) module. The RRL module employs a convolutional neural network (CNN) within the DRL agent, which performs spatiotemporal feature encoding and dynamically recovers a policy from its reward-guided learning method. To ensure interpretability, the explainable prognosis transformer (XPT) is utilized, which contains clinical contextual positional encoding and a hierarchical attention mechanism to enable transparent and reliable decision-making. This duality in the Rehab-DRLX architecture enables effective forecasting of the recovery outcomes, including functional independence probability, with both interpretability and accuracy, addressing the drawbacks of conventional black box prognosis tools. The experimental results of Rehab-DRLX show the noteworthy improvements in metrics such as accuracy (94.6%), F1-score (0.93), root mean square (RMSE) (0.082), and mean absolute error (MAE) (0.061) compared to existing studies. The ablation studies reveal the significant contribution of every architectural component and its overall performance. The results show the practical viability of Rehab-DRLX, which not only improves decision-making but also builds clinical trust through explainable insights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.